Literature DB >> 25700582

Screening for cancer: when to stop?: A practical guide and review of the evidence.

Michael C Soung1.   

Abstract

Deciding when to stop cancer screening in older adults is a complex challenge that involves multiple factors: individual health status and life expectancy; risks and benefits of screening, which vary with age and comorbidity; and individual preferences and values. This article examines current cancer screening practices and reviews the risks and benefits of cancer screening for colorectal, breast, lung, prostate, and cervical cancer, particularly in older individuals and those with multiple comorbidities. Tools for estimating life expectancy are reviewed, and a practical framework is presented to guide discussions on when the harms of screening likely outweigh the benefits.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cancer screening; Cervical cancer; Colorectal cancer; Elderly; Life expectancy; Lung cancer; Prostate cancer

Mesh:

Year:  2014        PMID: 25700582     DOI: 10.1016/j.mcna.2014.11.002

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

1.  Breast Cancer Screening in Patients With Newly Diagnosed Lung and Colorectal Cancer: A Population-Based Study of Utilization.

Authors:  Gelareh Sadigh; Ruth C Carlos; Kevin C Ward; Jeffrey M Switchenko; Renjian Jiang; Kimberly E Applegate; Richard Duszak
Journal:  J Am Coll Radiol       Date:  2017-03-17       Impact factor: 5.532

2.  Older Adults' Views and Communication Preferences About Cancer Screening Cessation.

Authors:  Nancy L Schoenborn; Kimberley Lee; Craig E Pollack; Karen Armacost; Sydney M Dy; John F P Bridges; Qian-Li Xue; Antonio C Wolff; Cynthia Boyd
Journal:  JAMA Intern Med       Date:  2017-08-01       Impact factor: 21.873

3.  Histological outcomes in HPV-screened elderly women in Denmark.

Authors:  Gry St-Martin; Petra Hall Viborg; Ane Birgitte Telén Andersen; Berit Andersen; Jette Christensen; Dorthe Ejersbo; Hanne Nørgaard Heje; Kirsten Marie Jochumsen; Tonje Johansen; Lise Grupe Larsen; Elsebeth Lynge; Reza Rafiolsadat Serizawa; Marianne Waldstrøm
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.